Avalyn Pharma Inc AVLN
$37.39 $1.95 (5.50%) 1D
Last Updated: Sep 04, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Avalyn Pharma Inc Stock Halal?
Shariah Compliance Analysis of AVLN Stock
United States Health Care Small Cap No. As of September 2026, Avalyn Pharma Inc (AVLN) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Avalyn Pharma Inc does not pass Musaffa's business and financial screening criteria.
Avalyn Pharma, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Boston, Massachusetts and currently employs 51 full-time employees. The company went IPO on 2026-04-30. The firm's pipeline is focused on treating pulmonary fibrosis. The company has three approved oral antifibrotic therapies for pulmonary fibrosis: pirfenidone; nintedanib, and nerandomilast. Its clinically advanced candidates, AP01 and AP02, are inhaled formulations of pirfenidone and nintedanib for the treatment of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis, respectively. The company has completed ATLAS, a Phase 1b clinical trial of AP01 in patients with IPF. AP02 is being evaluated in AURA, a global Phase II clinical trial for the treatment of IPF. The company is also advancing AP03 into a Phase I clinical trial. AP03 is a fixed-dose combination of inhaled pirfenidone, and nintedanib designed to deliver dual antifibrotic mechanisms with the potential for additive or synergistic benefit.
AVLN Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Avalyn Pharma Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Avalyn Pharma Inc (AVLN) Chart
Financial Metrics & Statements of Avalyn Pharma Inc (AVLN)
FAQ's for Avalyn Pharma Inc (AVLN)
- As of September 2026, Avalyn Pharma Inc AVLN is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Avalyn Pharma Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Avalyn Pharma Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Avalyn Pharma Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Avalyn Pharma Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Avalyn Pharma Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Avalyn Pharma Inc (AVLN)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
